UBS ETC on CMCI Corn USD logo

UBS ETC on CMCI Corn USD (CORU)

Market Closed
26 Feb, 15:30
LSE LSE
$
72. 37
+0.44
+0.61%
$
- Market Cap
2.2% Div Yield
244 Volume
$ 71.93
Previous Close
Day Range
72.37 72.37
Year Range
71.18 72.53
Want to track CORU and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
COR earnings report is expected in 65 days (5 May 2026)

Summary

CORU closed Thursday higher at $72.37, an increase of 0.61% from Wednesday's close, completing a monthly increase of 3.03% or $2.13. Over the past 12 months, CORU stock gained 0.75%.
CORU pays dividends to its shareholders, with the most recent payment made on Dec 01, 2025. The next announced payment will be in In 1 day on Mar 02, 2026 for a total of $0.6.
The last earnings report, released on Feb 04, 2026, exceeded the consensus estimates by 0.04%. On average, the company has surpassed earnings expectations by 0.03%, based on the last three reports. The next scheduled earnings report is due on May 05, 2026.
UBS ETC on CMCI Corn USD has completed 4 stock splits, with the recent split occurring on Jun 16, 2009.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on NYSE (USD).

CORU Chart

COR's MWI Animal Health to Merge With Covetrus in $3.5 Billion Deal

COR's MWI Animal Health to Merge With Covetrus in $3.5 Billion Deal

Cencora is set to merge MWI Animal Health with Covetrus in a $3.5B deal, retaining a 34.3% stake as it unlocks capital and targets animal health growth.

Zacks | 1 week ago
Cencora's animal health unit to merge with Covetrus in $3.5 billion deal

Cencora's animal health unit to merge with Covetrus in $3.5 billion deal

Drug distributor Cencora will merge its MWI Animal Health unit with privately held Covetrus in a deal that values MWI at $3.5 billion, the companies said on Wednesday.

Reuters | 1 week ago
Is the Options Market Predicting a Spike in Cencora Stock?

Is the Options Market Predicting a Spike in Cencora Stock?

Investors need to pay close attention to COR stock based on the movements in the options market lately.

Zacks | 1 week ago

UBS ETC on CMCI Corn USD (CORU) FAQ

What is the stock price today?

The current price is $72.37.

On which exchange is it traded?

UBS ETC on CMCI Corn USD is listed on LSE.

What is its stock symbol?

The ticker symbol is CORU.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.2%.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 4.89.

When is the next earnings date?

The next earnings report will release on May 05, 2026.

Has UBS ETC on CMCI Corn USD ever had a stock split?

UBS ETC on CMCI Corn USD had 4 splits and the recent split was on Jun 16, 2009.

UBS ETC on CMCI Corn USD Profile

LSE Exchange
US Country

Overview

Cencora, Inc., previously known as AmerisourceBergen Corporation, represents a cornerstone in the pharmaceutical distribution industry. Established in 2001 and headquartered in Conshohocken, Pennsylvania, the company specializes in sourcing and distributing pharmaceutical products across various markets. Its operation spans a comprehensive array of services targeted at facilitating the accessibility and distribution of pharmaceuticals, healthcare products, and related services. Cencora's business operations are segmented into U.S. Healthcare Solutions and International Healthcare Solutions, each catering to a diverse range of customers and needs within the healthcare and pharmaceutical sectors.

Products and Services

U.S. Healthcare Solutions:

  • Distribution Services: Includes distributing pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide range of healthcare providers such as acute care hospitals, retail pharmacies, and mail order pharmacies.
  • Pharmacy Management and Consulting Services: Offers pharmacy management, staffing, supply management software, and consulting services to retail and institutional healthcare providers.
  • Packaging Solutions: Provides innovative packaging solutions to institutional and retail healthcare providers to ensure safety and efficiency in medication dispensing.
  • Support Services for Clinical Trials: Offers clinical trial support, product post-approval, and commercialization support services, coupled with data analytics and research services for biotechnology and pharmaceutical manufacturers.
  • Veterinary Products and Services: Distributes pharmaceuticals, vaccines, and other products for companion and production animals, along with providing sales force services to manufacturers.
  • Specialty Products and Services: Involves the distribution of plasma and other blood products, injectable pharmaceuticals, vaccines, and offers services to physicians specializing in various disease states, including oncology, hospitals, and dialysis clinics.

International Healthcare Solutions:

  • Pharmaceutical Wholesale and Related Service: Offers international pharmaceutical wholesale, distribution, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe.
  • Global Commercialization Services: Provides global commercialization services to enhance the reach and impact of pharmaceutical products across international markets.
  • Specialty Transportation and Logistics: Delivers specialty transportation and logistics services tailored for the biopharmaceutical industry, focusing on the secure and efficient delivery of pharmaceutical products.

Contact Information

Address: 1 West First Avenue
Phone: 610 727 7000